|
|
|
Insider
Information: |
Feczko Joseph M |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
548,855 |
|
Indirect Shares
|
22,293 |
|
|
Direct
Value |
$12,694,108 |
|
|
Indirect Value
|
$659,873 |
|
|
Total
Shares |
571,148 |
|
|
Total
Value |
$13,353,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pfizer Inc |
PFE |
Senior Vice President |
2009-02-26 |
428,855 |
2009-02-26 |
22,293 |
Premium* |
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2015-06-17 |
120,000 |
|
0 |
Premium* |
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-10-20 |
0 |
2013-09-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CCXI |
Chemocentryx, Inc. |
Director |
|
2022-10-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(148,127) |
0 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-04-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
800 |
2,925 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-04-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,300 |
348,772 |
0 |
- |
|
PFE |
Pfizer Inc |
officerTitle |
|
2005-03-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
22,681 |
|
- |
|
PFE |
Pfizer Inc |
officerTitle |
|
2005-03-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
246,531 |
|
- |
|
PFE |
Pfizer Inc |
officerTitle |
|
2005-03-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
202,626 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Director |
|
2010-07-16 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
PFE |
Pfizer Inc |
Vice President |
|
2006-02-15 |
4 |
OE |
$12.42 |
$65,823 |
I/I |
4,320 |
8,391 |
|
- |
|
PFE |
Pfizer Inc |
Vice President |
|
2006-04-21 |
4 |
OE |
$12.42 |
$417,312 |
D/D |
33,600 |
340,910 |
|
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-02-13 |
4 |
OE |
$18.35 |
$1,276,279 |
D/D |
69,552 |
385,005 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2015-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,027 |
37,027 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2016-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,795 |
48,822 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2017-05-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,362 |
69,184 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
Director |
|
2022-01-21 |
4 |
OE |
$14.42 |
$577,750 |
D/D |
37,500 |
148,127 |
0 |
- |
|
PFE |
Pfizer Inc |
Vice President |
|
2006-02-15 |
4 |
S |
$25.27 |
$109,166 |
I/I |
(4,320) |
6,339 |
|
- |
|
PFE |
Pfizer Inc |
Vice President |
|
2006-04-21 |
4 |
S |
$25.07 |
$842,352 |
D/D |
(33,600) |
307,310 |
|
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-02-13 |
4 |
S |
$26.31 |
$1,829,913 |
D/D |
(69,552) |
315,453 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-04-23 |
4 |
S |
$26.61 |
$454,685 |
D/D |
(17,087) |
334,719 |
0 |
- |
|
PFE |
Pfizer Inc |
Senior Vice President |
|
2007-04-23 |
4 |
S |
$26.59 |
$105,881 |
I/I |
(3,982) |
0 |
0 |
- |
|
44 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|